Highly efficient and tumor-selective nanoparticles for dual-targeted immunogene therapy against cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Highly efficient and tumor-selective nanoparticles for dual-targeted immunogene therapy against cancer
Authors
Keywords
-
Journal
Science Advances
Volume 6, Issue 3, Pages eaax5032
Publisher
American Association for the Advancement of Science (AAAS)
Online
2020-01-16
DOI
10.1126/sciadv.aax5032
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Delivery technologies for cancer immunotherapy
- (2019) Rachel S. Riley et al. NATURE REVIEWS DRUG DISCOVERY
- An Efficient Combination Immunotherapy for Primary Liver Cancer by Harmonized Activation of Innate and Adaptive Immunity in Mice
- (2019) Liang Wen et al. HEPATOLOGY
- A multifunctional nanocarrier for efficient TRAIL-based gene therapy against hepatocellular carcinoma with desmoplasia in mice
- (2018) Chun-Hung Liu et al. HEPATOLOGY
- Programmed death ligand 1 promotes lymph node metastasis and glucose metabolism in cervical cancer by activating integrin β4/SNAI1/SIRT3 signaling pathway
- (2018) Shaojia Wang et al. ONCOGENE
- Prospects of IL-2 in Cancer Immunotherapy
- (2018) Hani Choudhry et al. Biomed Research International
- The hallmarks of successful anticancer immunotherapy
- (2018) Lorenzo Galluzzi et al. Science Translational Medicine
- Tumor-Intrinsic PD-L1 Signaling in Cancer Initiation, Development and Treatment: Beyond Immune Evasion
- (2018) Peixin Dong et al. Frontiers in Oncology
- Challenges and opportunities in the clinical development of immune checkpoint inhibitors for hepatocellular carcinoma
- (2018) Michael J Flynn et al. HEPATOLOGY
- Efficacy and safety of anti-PD-1 and anti-PD-1 combined with anti-CTLA-4 immunotherapy to advanced melanoma
- (2017) Chunyan Hao et al. MEDICINE
- Dendrimers as Nanocarriers for Nucleic Acid and Drug Delivery in Cancer Therapy
- (2017) Livia Palmerston Mendes et al. MOLECULES
- Targeting Tumor-Associated Fibroblasts for Therapeutic Delivery in Desmoplastic Tumors
- (2016) Lei Miao et al. CANCER RESEARCH
- The Vaccine Adjuvant Chitosan Promotes Cellular Immunity via DNA Sensor cGAS-STING-Dependent Induction of Type I Interferons
- (2016) Elizabeth. C. Carroll et al. IMMUNITY
- Expansion and Activation of CD103 + Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition
- (2016) Hélène Salmon et al. IMMUNITY
- Development of immuno-oncology drugs — from CTLA4 to PD1 to the next generations
- (2016) Axel Hoos NATURE REVIEWS DRUG DISCOVERY
- Local and transient gene expression primes the liver to resist cancer metastasis
- (2016) T. J. Goodwin et al. Science Translational Medicine
- Dendritic Cells and Cancer Immunity
- (2016) Alycia Gardner et al. TRENDS IN IMMUNOLOGY
- IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and Tolerance
- (2016) David H. Munn et al. TRENDS IN IMMUNOLOGY
- The Role of Prostaglandin E 2 in Tumor-Associated Immunosuppression
- (2016) Dingzhi Wang et al. TRENDS IN MOLECULAR MEDICINE
- The efficacy of a novel vaccine approach using tumor cells that ectopically express a codon-optimized murine GM-CSF in a murine tumor model
- (2016) Chu-Chi Lin et al. VACCINE
- The tumour microenvironment harbours ontogenically distinct dendritic cell populations with opposing effects on tumour immunity
- (2016) Damya Laoui et al. Nature Communications
- Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints
- (2016) Shohei Koyama et al. Nature Communications
- Novel GM-CSF-based vaccines: One small step in GM-CSF gene optimization, one giant leap for human vaccines
- (2016) Ting-Wei Yu et al. Human Vaccines & Immunotherapeutics
- CXCR4 inhibition in tumor microenvironment facilitates anti-programmed death receptor-1 immunotherapy in sorafenib-treated hepatocellular carcinoma in mice
- (2015) Yunching Chen et al. HEPATOLOGY
- Principles of nanoparticle design for overcoming biological barriers to drug delivery
- (2015) Elvin Blanco et al. NATURE BIOTECHNOLOGY
- An orthotopic mouse model of hepatocellular carcinoma with underlying liver cirrhosis
- (2015) Thomas Reiberger et al. Nature Protocols
- Focusing and sustaining the antitumor CTL effector killer response by agonist anti-CD137 mAb
- (2015) Bettina Weigelin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Designed nucleus penetrating thymine-capped dendrimers: a potential vehicle for intramuscular gene transfection
- (2015) Jia-Ying Yan et al. Journal of Materials Chemistry B
- IL-2: The First Effective Immunotherapy for Human Cancer
- (2014) S. A. Rosenberg JOURNAL OF IMMUNOLOGY
- Non-viral vectors for gene-based therapy
- (2014) Hao Yin et al. NATURE REVIEWS GENETICS
- Vascular Normalization as an Emerging Strategy to Enhance Cancer Immunotherapy
- (2013) Y. Huang et al. CANCER RESEARCH
- From Cirrhosis to Hepatocellular Carcinoma: New Molecular Insights on Inflammation and Cellular Senescence
- (2013) Gayatri Ramakrishna et al. Liver Cancer
- Calcium phosphate nanoparticles with an asymmetric lipid bilayer coating for siRNA delivery to the tumor
- (2011) Jun Li et al. JOURNAL OF CONTROLLED RELEASE
- TGF-β and immune cells: an important regulatory axis in the tumor microenvironment and progression
- (2010) Li Yang et al. TRENDS IN IMMUNOLOGY
- Hepatocellular carcinoma cell-specific peptide ligand for targeted drug delivery
- (2008) A. Lo et al. MOLECULAR CANCER THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search